Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Mitchell

Showing results (61-70 of 249) with videos related to

Pageof 25
Sort By:
Nature Biotechnology|January 4, 2003
Antisoma-Roche deal--a new kind of buyout?Peter Mitchell
Nature Biotechnology|May 31, 2003
Germany contemplates new biotech tax schemePeter Mitchell
Lancet (London, England)|October 20, 2001
Human xenotransplantation trials may be licensed in the UKPeter Mitchell
Nature Biotechnology|September 10, 2005
Europe caught in innovation quagmirePeter Mitchell
Nature Biotechnology|March 11, 2008
Investor malaise stalks UK, European biotechPeter Mitchell
Transactions of the Medical Society of London|December 23, 2006
The winds of changePeter Mitchell-Heggs
Journal of Experimental Child Psychology|September 25, 2004
Five-year-old children's difficulty with false belief when the sought entity is a personRoshan Rai, Peter Mitchell
Journal of Speech, Language, and Hearing Research : JSLHR|March 15, 2006
Text chat as a tool for referential questioning in Asperger syndromeGnanathusharan Rajendran, Peter Mitchell
Nature Biotechnology|January 12, 2010
Investor volatility plagues drug companies on new Chinese exchangePeter Mitchell, Fu Jing
Plos One|January 13, 2021
An examination of perseverative errors and cognitive flexibility in autismOriane Landry, Peter Mitchell
Pageof 25

Showing results (61-70 of 249) with videos related to

Sort By:
Pageof 25
Nature Biotechnology|January 4, 2003
Antisoma-Roche deal--a new kind of buyout?Peter Mitchell
Nature Biotechnology|May 31, 2003
Germany contemplates new biotech tax schemePeter Mitchell
Lancet (London, England)|October 20, 2001
Human xenotransplantation trials may be licensed in the UKPeter Mitchell
Nature Biotechnology|September 10, 2005
Europe caught in innovation quagmirePeter Mitchell
Nature Biotechnology|March 11, 2008
Investor malaise stalks UK, European biotechPeter Mitchell
Transactions of the Medical Society of London|December 23, 2006
The winds of changePeter Mitchell-Heggs
Journal of Experimental Child Psychology|September 25, 2004
Five-year-old children's difficulty with false belief when the sought entity is a personRoshan Rai, Peter Mitchell
Journal of Speech, Language, and Hearing Research : JSLHR|March 15, 2006
Text chat as a tool for referential questioning in Asperger syndromeGnanathusharan Rajendran, Peter Mitchell
Nature Biotechnology|January 12, 2010
Investor volatility plagues drug companies on new Chinese exchangePeter Mitchell, Fu Jing
Plos One|January 13, 2021
An examination of perseverative errors and cognitive flexibility in autismOriane Landry, Peter Mitchell
Pageof 25